Direct Sales Operation Through Joint Venture With Largest Chinese Aesthetic Hospital Chain Aims to Secure Syneron Leadership in Chinese Market

YOKNEAM, ISRAEL -- (Marketwire) -- 11/19/08 -- Syneron Medical Ltd. (NASDAQ: ELOS), an innovator in the development, marketing and sales of elos(TM) combined-energy medical aesthetic devices, today announced the signing of a joint venture agreement establishing Syneron China.

Syneron's partner in Syneron China is the EverCare Medical Group, the largest aesthetic hospital chain in China. Evercare operates cosmetic surgery hospitals throughout the country and has been Syneron's distributor in China for the past two years.

Through this new Chinese subsidiary, Syneron will sell directly to medical and aesthetic professionals in China, including doctors, hospitals, medi-spas, and cosmetic chains. Syneron China will also provide training and after sales service and support. The first two offices of Syneron China were opened in Beijing and Guangzhou in August 2008. The Shanghai office is scheduled to be opened in December 2008, and two other offices will be opened by the summer of 2009. In addition to the five main offices, Syneron China will establish product demonstration centers across China.

Commenting on the joint venture, Doron Gerstel, Syneron CEO, said, "Syneron's partnership with the EverCare Medical Group positions the company to gain greater penetration of the Chinese medical aesthetic sector. Syneron's new direct operation in China, with a strong local management team, will ensure success in securing a truly dominant market share and standardizing Syneron's high quality customer care."

Syneron selected the EverCare Medical Group as a partner because of their high level of professionalism and the success of the collaboration with EverCare both as a major end user of Syneron devices in their hospitals, as well as a distributor of Syneron platforms to the Chinese medical sector.

"The EverCare doctors and professionals have been using Syneron equipment extensively in their hospitals, making the EverCare team a knowledgeable, respected resource base to demonstrate Syneron platforms and the benefits of the elos technology across China," continued Gerstel. "Working with the EverCare physician and sales teams, we aim to greatly increase the installed base of Syneron platforms in China."

Dr. James Wang, President of EverCare Medical Ltd., remarked, "With 15 years of experience in the Chinese aesthetic market, I have worked with almost all major international aesthetic medical device companies. Two years ago, we chose to equip all EverCare hospitals with Syneron's aesthetic medical devices for facial applications and body shaping, as well as to act as a Syneron distributor, due to the superior treatment results and strong safety record of the Syneron equipment.